CTOs on the Move


 
Octave Health is the nation`s first practice supporting all aspects of emotional well-being.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.findoctave.com
  • 286 Madison Ave 22nd Floor
    New York, NY USA 10017
  • Phone: 415.360.3833

Executives

Name Title Contact Details

Funding

Octave raised $11M on 10/22/2019
Octave raised $20M on 05/25/2021

Similar Companies

Plasmatech Biopharmaceuticals

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.

Neurology Partners

Neurology Partners is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medifacts International

Medifacts International, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cuattro

Cuattro is a Pekin, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Namaste Technologies

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada`s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada`s largest database of medical cannabis patients. The company`s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.